Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis

• Main Authors: Kim Rand (Author), Juan Manuel Ramos-Goñi (Author), Bülent Akmaz (Author), Laia Solé-Feu (Author), José-Carlos A (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Item Description

10.1007/s13555-023-01076-x
2193-8210
2190-9172